The St. Louis Business Journal recently named David M. Jackson to its 2014 “30 Under 30” class. David is the managing partner of the Gate Way Group, the lobbying and association-management division of public-affairs and advocacy firm Pelopidas, LLC.
The Business Journal selects prominent business leaders and entrepreneurs each year for this prestigious award. These young professionals are chosen from a diverse group of candidates across the St. Louis region, with past winners ranging from Jessica Schanbacher, Senior Vice President of Associated Bank, to Don Calloway, a former Missouri State Representative who now serves as Director of National Affairs at Anheuser-Busch in Washington, D.C.
As the managing partner of the Gate Way Group, David is responsible for shaping the legislative strategy and vision for Gate Way’s broad lobbying and association management client base that stretches across nearly every business sector. In addition to managing relationships with hundreds of local, state, and federal elected officials, David and his team work with other divisions in the Pelopidas, LLC network to integrate digital media, events, and data strategies into a multidimensional, customized action plan for each client, policy initiative, and brand.
Posted by Dave Berry By Ben Kleine JEFFERSON CITY, Mo. — Two weeks ago, Ewell Lawson, Manager of Government Operations for the Missouri Association of Municipal Utilities was the most vocal opponent of SB 650 and 653, sponsored by Sen. Brad Lager, R-Savannah. He was singing a different tune in the House Utilities hearing for[…]
JEFFERSON CITY, Mo. (AP) — A Missouri Senate committee advanced broad education legislation Thursday that could open the door for students attending struggling public schools to use district funds to transfer to private schools.
The measure seeks to address troubled districts and a state transfer law requiring unaccredited school systems to pay for students to transfer to better-performing nearby public schools.
JEFFERSON CITY, Mo. (AP) — The Missouri Senate has given first-round approval to legislation that could lower treatment costs for some cancer patients.
The measure endorsed Tuesday would let insurance companies charge patients only $75 more per month for chemotherapy pills than traditional intravenous chemotherapy treatments.
Patients are often charged much more for oral chemotherapy because it is handled as a pharmacy benefit. Intravenous treatments often only cost the standard co-payment for an office visit.
JEFFERSON CITY • A House committee on Wednesday endorsed legislation to cap some awards in medical malpractice cases.
The measures would limit non-economic damages for medical malpractice lawsuits to $350,000. That limit would not apply to economic damages such as lost wages or hospital bills.
Supporters say the legislation is necessary to keep medical malpractice insurance premiums from soaring and potentially driving doctors out of the state, or at least making it more difficult for them to stay in business.
Posted by Dave Berry Gate Way Group Contact: David Jackson Price Transparency in Health Care: The Kansas City Star ran a series of articles in December that zeroed in on hospital employed physicians, facility fees, and price transparency in health care. This week, Senator Jason Holsman (D-Kansas City), filed legislation that would allow patients to[…]
Posted by Dave Berry Gate Way Group Contact: David Jackson Senate Hears Bill to Tighten Regulations on Navigators: The introduction of health insurance navigators through the Affordable Care Act (ACA) has prompted strong defensive efforts from health insurance agents. Senator Kurt Schaefer (R-Columbia) presented Senate Bill 498 on Tuesday in the Senate Small Business, Insurance,[…]